AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2024
Sep 9, 2024
30016_dirs_2024-09-09_79bdd650-06e4-4734-b92b-428b8f929603.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2024-09-05
Reporting Person: SZOSTAK M ANNE (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-09-05 | Common Stock | G | 500 | — | Disposed | 6061 | Indirect |
| 2024-09-05 | Common Stock | G | 500 | — | Acquired | 500 | Indirect |
| 2024-09-06 | Common Stock | S | 500 | $469.3723 | Disposed | 0 | Indirect |
Footnotes
F1: The reporting person is the settlor of the Trust of M. Anne Szostak ("Trust") and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares held by the Trust.
F2: The reporting person is a trustee of The O'Hanian-Szostak Family Foundation ('Foundation') and has power to direct the distribution of assets held by the Foundation.
F3: Represents the weighted average price of the shares sold ranging from a low of $468.98 to a high of $469.55 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.